Literature DB >> 8061421

Dose of contrast material in the MR imaging evaluation of central nervous system tumors.

W T Yuh1, J I Halloran, N A Mayr, D J Fisher, H D Nguyen, T M Simonson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8061421     DOI： 10.1002/jmri.1880040304

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN： 1053-1807            Impact factor:   4.813


× No keyword cloud information.
  4 in total

Review 1.  MR imaging of neoplastic central nervous system lesions: review and recommendations for current practice.

Authors:  M Essig; N Anzalone; S E Combs; À Dörfler; S-K Lee; P Picozzi; A Rovira; M Weller; M Law
Journal:  AJNR Am J Neuroradiol       Date:  2011-10-20       Impact factor: 3.825

2.  Additional MR contrast dosage for radiologists' diagnostic performance in detecting brain metastases: a systematic observer study at 3 T.

Authors:  Osamu Togao; Akio Hiwatashi; Koji Yamashita; Kazufumi Kikuchi; Takashi Yoshiura; Hiroshi Honda
Journal:  Jpn J Radiol       Date:  2014-06-24       Impact factor: 2.374

3.  [Contrast-enhanced MR "magnetization transfer technique". Improved tumor contrast, delineation and visibility of intracranial malignant gliomas and metastases in radiosurgical treatment planning].

Authors:  H Hawighorst; W Schreiber; J Debus; M V Knopp; R Engenhart-Cabillic; G Brix; M Essig; G van Kaick
Journal:  Strahlenther Onkol       Date:  1997-12       Impact factor: 3.621

Review 4.  Improving lesion detection and visualization: implications for neurosurgical planning and follow-up.

Authors:  Piero Picozzi; Miles A Kirchin
Journal:  Neuroradiology       Date:  2007-07       Impact factor: 2.804
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.